AlphaStocks
3.8
Weak

HCA Healthcare, Inc. (HCA)

Health Care / Health Care Facilities

S&P 500

$429.56

Scores poorly across most models. Proceed with caution.

Weak

Score based on 5 of 5 models — high confidence

#879out of 1126 in Health Care

Is HCA Healthcare, Inc. a Good Investment in 2026?

HCA Healthcare, Inc. (HCA) scores 3.8 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Greenblatt Magic Formula model rates HCA Healthcare, Inc. as Strong (Top half (rank 26%)). The Graham model is the least favorable, rating it Neutral. HCA Healthcare, Inc. currently trades below its estimated fair value of $663, suggesting potential upside. HCA Healthcare, Inc. ranks #879 out of 1126 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E15.2ROE-119.4Market Cap97BDiv Yield0.7

Estimated Fair Value

$663.4235% below

Fair value above market price. EPS grew 29% year-over-year. P/E of 15x is moderate for this quality level.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

6/9

Buffett

Neutral

Business quality & competitive moat

Graham

Neutral

Price vs intrinsic value

Lynch

Attractive

PEG 1.0 · Fast Grower

Greenblatt

Strong

Top half (rank 26%)

Frequently Asked Questions

Is HCA Healthcare, Inc. (HCA) a good investment?
Based on AlphaStocks' composite analysis, HCA Healthcare, Inc. (HCA) scores 3.8 out of 10, earning a Weak rating. This score is below average, suggesting caution. Fair value above market price. EPS grew 29% year-over-year. P/E of 15x is moderate for this quality level.
What is HCA Healthcare, Inc.'s Piotroski F-Score?
HCA Healthcare, Inc.'s Piotroski F-Score status is Attractive. The raw score is 6/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is HCA overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $663, HCA appears undervalued. The stock currently trades 35% below its estimated fair value. Fair value above market price. EPS grew 29% year-over-year. P/E of 15x is moderate for this quality level.
How does HCA compare to other Health Care stocks?
HCA Healthcare, Inc. ranks #879 out of 1126 stocks in the Health Care sector, placing it in the top 78% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about HCA?
AlphaStocks evaluates HCA using five proven investment models. Piotroski: Attractive; Buffett: Neutral; Graham: Neutral; Lynch: Attractive; Greenblatt Magic Formula: Strong. These models are combined into a single composite score of 3.8/10.

Similar Stocks

PARRAZNFTI

Compare HCA with

HCA vs PARRHCA vs AZNHCA vs FTI

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer